MECOM and neoplasm: The tumor origin of these cells was confirmed by the identification of shared mutations in the MDS1 and EVI1 complex locus, myosin 11, and neurofibromin 1, as well as the platelet-derived growth factor receptor Alpha and the amplification of the endothelial growth factor receptor [192].